申请人:GUANGDONG RAYNOVENT BIOTECH CO., LTD.
公开号:US20210032238A1
公开(公告)日:2021-02-04
The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
本发明公开了一类抗流感病毒化合物,以及其在制备用于治疗与流感病毒相关疾病的药物中的应用。具体而言,本发明公开了一种由式(I)表示的化合物及其药用可接受的盐。